Skip to content

Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient

Real World Status of Palliative Care for Pancreatic Cancer Patients in China-a National Multi-center Cross-sectional Survey

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06090825
Enrollment
450
Registered
2023-10-19
Start date
2023-09-01
Completion date
2025-09-01
Last updated
2023-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Keywords

follow up, palliative care, pancreatic cancer

Brief summary

It is a real-world observational cross-sectional follow-up study on clinical palliative care for pancreatic cancer patients in China. It is evaluated by an online questionnaire sent to the doctors from the General Surgery Department in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland.

Detailed description

Pancreatic cancer is a highly malignant gastrointestinal tumor with only a 10% overall 5-year survival rate. More than 80% of patients are already in the advanced stage when diagnosed, losing the chance of surgery. Advanced pancreatic cancer progresses rapidly and chemoradiotherapy has limited efficacy, so palliative care is thought to play an important role in the treatment process. However, due to the late development of palliative care, there is a lack of data on real-world clinical palliative care for pancreatic cancer patients in China. This study investigates the real-world current status of palliative care for pancreatic cancer patients by sending a web questionnaire to the doctors from the Department of General Surgery in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland. The survey aims to obtain the real status of palliative care and achieve a comprehensive understanding of how to develop palliative care in hospitals. The questionnaire includes both subjective standards like the surgeons' opinion on the development of palliative therapy and objective standards such as dedicated beds and teams for palliative care.

Interventions

OTHERObservational study

Observational study

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Doctors from the General Surgery Department in Chinese public tertiary teaching hospitals and public primary care units * Approval to participate * Participants with a valid and complete questionnaire evaluated by 2 experienced surgeons

Exclusion criteria

* Refusal to participate * Participants with an invalid or incomplete questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Descriptions and scores of real status of hospice care in different hospitals1 monthThe primary outcome is objective standards and subjective scores of current status of palliative care to qutify the development of palliative care of different hospitals. The score is evaluated by a follow-up questionnaire. The maximum and minimum score is 10 and 0, respectively.

Countries

China

Contacts

Primary ContactQiaofei Liu
qfliu@aliyun.com8615201693370
Backup ContactYuze Hua
huayuze97@163.com8617813719961

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026